Catalife
Photocatalysts for Purification and Photodisinfection
Company Overview
Snapshot
Founded in August 2018 by Dr. Hani Gnayem, Catalife operated with 1–10 employees. The company focused on developing innovative photocatalyst technology. In April 2020, Catalife was noted for its scientific contributions to global health efforts.
Business overview
Catalife is an Industrial Technologies company specializing in purification and photodisinfection solutions. The company develops innovative technology based on a family of photocatalysts activated by visible light, aiming to provide solutions for air, water, fabrics, and self-cleaning surfaces. Catalife's core product is its photocatalyst technology, which serves markets including manufacturing facilities, hospitals, and the food and beverage industry, operating within sectors such as materials, water treatment, and clean air.
Strategic signal
In April 2020, Catalife was highlighted in a JPost.com article for its scientific contributions, specifically noting how Israeli scientists, including those from Catalife, were recruiting to help with the global epidemic. This indicates the company's technology had recognized potential for broader societal impact and validation of its scientific expertise, signaling its relevance in critical public health challenges.
Log in to access full profile ›Company Intelligence Q&A
- What is Catalife's primary focus?
- Catalife aims to be a leading solutions provider in the field of purification and photodisinfection of air, water, fabrics, and self-cleaning surfaces, utilizing innovative photocatalyst technology.
- When was Catalife founded?
- Catalife was founded in August 2018.
- Who is a co-founder of Catalife?
- Dr. Hani Gnayem is a co-founder of Catalife.
- What is the core technology behind Catalife's solutions?
- Catalife's innovative technology is based on a family of photocatalysts activated over visible light, designed for purification and photodisinfection.
- What was a notable public mention for Catalife?
- In April 2020, Catalife was mentioned in a JPost.com article highlighting how Israeli scientists were contributing to global epidemic efforts, showcasing the potential impact of the company's work.